Today, our screeners were at work and below is a list of 4 HealthTech Stocks up over 79% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
Summary: ImmunoGen Inc is a development-stage biotechnology company focused on the development of targeted cancer therapeutics using its proprietary antibody-drug conjugate technology. ImmunoGen's ADC technology is used in three development-stage candidates in its own pipeline, Roche's marketed product, Kadcyla and in development programs of its partners Bayer, Biotest, CytomX, Novartis, Sanofi, Roche, Takeda, Debiopharm & Jazz Pharmaceuticals.'Among ImmunoGen's wholly owned candidates, mirvetuximab soravtansine, a first-in-class ADC targeting folate-receptor alpha, is being developed as a single-agent therapy for platinum-resistant ovarian cancer and in combination regimens for both platinum-resistant and platinum-sensitive disease.
Recent IMGN Stock Price (approx 10:00am EST.): $13.43
Previous Close for IMGN Stock: $13.28
Percentage Price Change Past 10 Days for IMGN stock: +212%
|
What is the forecast for IMGN stock? Here are 3rd party ratings for IMGN stock:
|
What’s the sentiment on the street for IMGN stock? Current ratings compiled by TipRanks.com)
|
Click for the IMGN stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Elevation Oncology Inc. is a clinical stage biopharmaceutical company. It focused on the development of precision medicines for patients with genomically defined cancers. Elevation Oncology Inc. is based in NEW YORK.
Recent ELEV Stock Price (approx 10:00am EST.): $3.63
Previous Close for ELEV Stock: $3.5
Percentage Price Change Past 10 Days for ELEV stock: +91%
|
What is the forecast for ELEV stock? Here are 3rd party ratings for ELEV stock:
|
What’s the sentiment on the street for ELEV stock? Current ratings compiled by TipRanks.com)
|
Click for the ELEV stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.
Recent NERV Stock Price (approx 10:00am EST.): $5.09
Previous Close for NERV Stock: $4.61
Percentage Price Change Past 10 Days for NERV stock: +87%
|
What is the forecast for NERV stock? Here are 3rd party ratings for NERV stock:
|
What’s the sentiment on the street for NERV stock? Current ratings compiled by TipRanks.com)
|
Click for the NERV stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company. It is engaged in developing a class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform which is designed to reprogram the body's immune system. HOOKIPA Pharma Inc. is based in New York, United States.
Recent HOOK Stock Price (approx 10:00am EST.): $1.44
Previous Close for HOOK Stock: $1.36
Percentage Price Change Past 10 Days for HOOK stock: +79%
|
What is the forecast for HOOK stock? Here are 3rd party ratings for HOOK stock:
|
What’s the sentiment on the street for HOOK stock? Current ratings compiled by TipRanks.com)
|
Click for the HOOK stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
